0.97
-0.0123(-1.25%)
Currency In USD
| Previous Close | 0.98 |
| Open | 0.96 |
| Day High | 0.99 |
| Day Low | 0.95 |
| 52-Week High | 3.94 |
| 52-Week Low | 0.69 |
| Volume | 749,145 |
| Average Volume | 5.16M |
| Market Cap | 192.67M |
| PE | -1.14 |
| EPS | -0.85 |
| Moving Average 50 Days | 0.97 |
| Moving Average 200 Days | 1.73 |
| Change | -0.01 |
If you invested $1000 in Esperion Therapeutics, Inc. (ESPR) 10 years ago, it would be worth $11.82 as of July 01, 2025 at a share price of $0.972. Whereas If you bought $1000 worth of Esperion Therapeutics, Inc. (ESPR) shares 5 years ago, it would be worth $19.02 as of July 01, 2025 at a share price of $0.972.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Esperion Appoints Craig Thompson to Board of Directors
GlobeNewswire Inc.
3 hours ago
Brings More Than Twenty Years of Biopharmaceutical Leadership ExperienceANN ARBOR, Mich., July 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it has appointed Craig Thompson, Chief Executive Officer of Cerevance, to its Board
Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
GlobeNewswire Inc.
Jun 02, 2025 12:00 PM GMT
ANN ARBOR, Mich., June 02, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Limited, Hetero Labs Limited Unit-V, and Honour Lab Lim
Esperion to Participate in Upcoming June Investor Conferences
GlobeNewswire Inc.
May 20, 2025 12:00 PM GMT
ANN ARBOR, Mich., May 20, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of June, which can be found on our investor relations webs